what are the effects of tirzepatide Side Effects: Timeline, Symptoms, Weight Regain & Long-Term Safety Retatrutide vs Tirzepatide (2026): Differences

These follow-on patents form a systematic attempt to add barriers of entry for generic competitors, with the intention of extending Novo Nordisks market monopoly for as long as possible when the main compound patent on the underlying active ingredient, semaglutide, expires

Editing by Arun Koyyur and Bill Berkrot)

GLP-1 is a hormone secreted by the gut in response to food, particularly certain nutrients

The injectable options include Ozempic , used for managing type 2 diabetes, and Wegovy , which focuses on weight management

What the Trials Have Actually Shown So Far A phase 2 trial published in the New England Journal of Medicine found that 48 weeks of treatment with retatrutide, an agonist of the GIP, GLP-1, and glucagon receptors, produced substantial reductions in body weight among participants with obesity

I 2 0%, 4 studies [15, 19,20,21]), coronary artery disease (RR 0.76, 95% CI 0.571.01